pteridines and cyclin d1

pteridines has been researched along with cyclin d1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Baulande, S; Bernard, V; Bièche, I; Bohec, M; Château-Joubert, S; Chemlali, W; Cottu, P; Coussy, F; Dahmani, A; Decaudin, D; Driouch, K; Dutertre, G; El Botty, R; Gentien, D; Huguet, L; Larcher, T; Le Romancer, M; Leal, MF; Marangoni, E; Martin, LA; Masliah-Planchon, J; Meseure, D; Montaudon, E; Morisset, L; Nemati, F; Nicolas, A; Nikitorowicz-Buniak, J; Painsec, P; Pancholi, S; Rapinat, A; Rega, C; Reyes, C; Ribas, R; Simigdala, N; Sourd, L; Tariq, Z; Vacher, S; Vincent-Salomon, A	1

Studies

Baulande, S; Bernard, V; Bièche, I; Bohec, M; Château-Joubert, S; Chemlali, W; Cottu, P; Coussy, F; Dahmani, A; Decaudin, D; Driouch, K; Dutertre, G; El Botty, R; Gentien, D; Huguet, L; Larcher, T; Le Romancer, M; Leal, MF; Marangoni, E; Martin, LA; Masliah-Planchon, J; Meseure, D; Montaudon, E; Morisset, L; Nemati, F; Nicolas, A; Nikitorowicz-Buniak, J; Painsec, P; Pancholi, S; Rapinat, A; Rega, C; Reyes, C; Ribas, R; Simigdala, N; Sourd, L; Tariq, Z; Vacher, S; Vincent-Salomon, A

Other Studies

1 other study(ies) available for pteridines and cyclin d1

Article	Year
PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance. Nature communications, 2020, 08-13, Volume: 11, Issue:1 Topics: Animals; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cyclin D1; DNA Copy Number Variations; Drug Resistance, Neoplasm; Exome Sequencing; G2 Phase Cell Cycle Checkpoints; Humans; Immunoblotting; Immunohistochemistry; Immunoprecipitation; Mice; Mice, Nude; Piperazines; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Pyridines	2020

Article

Year

PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance.

Nature communications, 2020, 08-13, Volume: 11, Issue:1

Topics: Animals; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cyclin D1; DNA Copy Number Variations; Drug Resistance, Neoplasm; Exome Sequencing; G2 Phase Cell Cycle Checkpoints; Humans; Immunoblotting; Immunohistochemistry; Immunoprecipitation; Mice; Mice, Nude; Piperazines; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Pyridines

2020